Clinical Trials Related to Dana-Farber Cancer Institute

Related studies linked through entity extraction aliases.

Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity

Status: COMPLETED
Phase: NA

Feasibility of Fasting & Exercise in Pts With HR+ MBC

Status: COMPLETED
Phase: NA

Sargramostim (GM-CSF) + PD-1

Status: WITHDRAWN
Phase: PHASE2

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

Status: RECRUITING
Phase: PHASE1

Digitally Enhanced Smoking Cessation for High Risk Smokers

Status: ACTIVE_NOT_RECRUITING
Phase: NA

IS-free Treg HaploHCT

Status: RECRUITING
Phase: PHASE1

Resilience and Equity in Aging, Cancer, and Health (REACH)

Status: RECRUITING
Phase: NA

Cabozantinib With Topotecan-Cyclophosphamide

Status: COMPLETED
Phase: PHASE1

Advance Care Planning: Communicating With Outpatients for Vital Informed Decision

Status: COMPLETED
Phase: N/A

Refining Local-Regional Therapy for IBC

Status: RECRUITING
Phase: NA

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Status: COMPLETED
Phase: PHASE1

Geriatric Thoracic Surgery Ambulation Challenge

Status: RECRUITING
Phase: NA

ABEMA Alone or in COMBO With MK-6482

Status: COMPLETED
Phase: PHASE1

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

Status: RECRUITING
Phase: PHASE2

Axi-cel in CNS Lymphoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Niraparib + Dostarlimab In BRCA Mutated Breast Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Copanlisib Plus Venetoclax in R/R DLBCL

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

My Mindful Moments: A Mindfulness Meditation and Digital Art Activity

Status: COMPLETED
Phase: NA

Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress

Status: RECRUITING
Phase: N/A